R v Lagana

Case

[2012] SASCFC 135

17 December 2012


Details
AGLC Case Decision Date
R v Lagana [2012] SASCFC 135 [2012] SASCFC 135 17 December 2012

CaseChat Overview and Summary

The appellant, R v Lagana, appealed to the Full Court of the Supreme Court of South Australia against a sentence imposed by a District Court judge. The appellant and a co-offender, Mr Keegan, were convicted of manufacturing a large commercial quantity of a controlled drug and manufacturing a controlled drug, both offences involving methylamphetamine. The appellant received a head sentence of seven years imprisonment with a non-parole period of five years, while Mr Keegan received a head sentence of seven years imprisonment with a non-parole period of six years, but due to unexpired parole, his total period in custody was significantly longer.

The primary legal issue before the Full Court was whether the sentence imposed on the appellant was manifestly excessive, with the appellant's real complaint focusing on the perceived disparity between his sentence and that of his co-offender, Mr Keegan. This raised the question of whether the principle of parity in sentencing, which dictates that like cases should be treated alike and that sentences on co-offenders should not exhibit such marked disparity as to create a justifiable sense of grievance, had been breached.

The Full Court, comprising Gray, Vanstone, and White JJ, dismissed the appeal. White J, in his reasons, noted that while the appellant's head sentence was seven years with a five-year non-parole period, the judge would have imposed eight years had it not been for the appellant's guilty plea. He highlighted that the appellant's true grievance concerned the disparity with Mr Keegan's sentence. However, the court found that the circumstances of the appellant and Mr Keegan were markedly dissimilar. The court considered the relevant facts of the offending, including the large quantity of pseudoephedrine being extracted, which could have yielded between five and eight kilograms of methylamphetamine with a potential wholesale value of $1.2 to $2.6 million. Ultimately, the court was not satisfied that the appellant had established any basis for a lack of parity or any justifiable sense of grievance, leading to the dismissal of the appeal.
Details

Areas of Law

  • Criminal Law

  • Statutory Interpretation

Legal Concepts

  • Appeal

  • Charge

  • Sentencing

  • Statutory Construction

Actions
Download as PDF Download as Word Document

Most Recent Citation
Sarvak v The Queen [2011] VSCA 300

Cases Citing This Decision

35

Schatto v The King [2022] SASCA 129
Schatto v The King [2022] SASCA 129
Cases Cited

15

Statutory Material Cited

1

R v Kong [2013] SASCFC 15
R v Cetojevic [2005] SASC 273
Everett v the Queen [1994] HCA 49